140 related articles for article (PubMed ID: 29115437)
61. MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models.
Tovar C; Graves B; Packman K; Filipovic Z; Higgins B; Xia M; Tardell C; Garrido R; Lee E; Kolinsky K; To KH; Linn M; Podlaski F; Wovkulich P; Vu B; Vassilev LT
Cancer Res; 2013 Apr; 73(8):2587-97. PubMed ID: 23400593
[TBL] [Abstract][Full Text] [Related]
62. Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.
Riscal R; Schrepfer E; Arena G; Cissé MY; Bellvert F; Heuillet M; Rambow F; Bonneil E; Sabourdy F; Vincent C; Ait-Arsa I; Levade T; Thibaut P; Marine JC; Portais JC; Sarry JE; Le Cam L; Linares LK
Mol Cell; 2016 Jun; 62(6):890-902. PubMed ID: 27264869
[TBL] [Abstract][Full Text] [Related]
63. Primate-specific miR-944 activates p53-dependent tumor suppression in human colorectal cancers.
Kim YJ; Lee JH; Jin S; Kim JH; Kim SH
Cancer Lett; 2019 Jan; 440-441():168-179. PubMed ID: 30393117
[TBL] [Abstract][Full Text] [Related]
64. The labdane diterpene sclareol (labd-14-ene-8, 13-diol) induces apoptosis in human tumor cell lines and suppression of tumor growth in vivo via a p53-independent mechanism of action.
Mahaira LG; Tsimplouli C; Sakellaridis N; Alevizopoulos K; Demetzos C; Han Z; Pantazis P; Dimas K
Eur J Pharmacol; 2011 Sep; 666(1-3):173-82. PubMed ID: 21620827
[TBL] [Abstract][Full Text] [Related]
65. Quercetin pretreatment enhances the radiosensitivity of colon cancer cells by targeting Notch-1 pathway.
Li Y; Wang Z; Jin J; Zhu SX; He GQ; Li SH; Wang J; Cai Y
Biochem Biophys Res Commun; 2020 Mar; 523(4):947-953. PubMed ID: 31964531
[TBL] [Abstract][Full Text] [Related]
66. Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe.
Tse AN; Schwartz GK
Cancer Res; 2004 Sep; 64(18):6635-44. PubMed ID: 15374978
[TBL] [Abstract][Full Text] [Related]
67. Identification of FES as a Novel Radiosensitizing Target in Human Cancers.
Kim BH; Kim YJ; Kim MH; Na YR; Jung D; Seok SH; Kim J; Kim HJ
Clin Cancer Res; 2020 Jan; 26(1):265-273. PubMed ID: 31573955
[TBL] [Abstract][Full Text] [Related]
68. MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapy.
Azmi AS; Philip PA; Beck FW; Wang Z; Banerjee S; Wang S; Yang D; Sarkar FH; Mohammad RM
Oncogene; 2011 Jan; 30(1):117-26. PubMed ID: 20818437
[TBL] [Abstract][Full Text] [Related]
69. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
[TBL] [Abstract][Full Text] [Related]
70. Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo.
Mu Z; Hachem P; Hensley H; Stoyanova R; Kwon HW; Hanlon AL; Agrawal S; Pollack A
Prostate; 2008 May; 68(6):599-609. PubMed ID: 18196567
[TBL] [Abstract][Full Text] [Related]
71. Dual inhibition of nuclear factor kappa-B and Mdm2 enhance the antitumor effect of radiation therapy for pancreatic cancer.
Shirai Y; Shiba H; Iwase R; Haruki K; Fujiwara Y; Furukawa K; Uwagawa T; Ohashi T; Yanaga K
Cancer Lett; 2016 Jan; 370(2):177-84. PubMed ID: 26546875
[TBL] [Abstract][Full Text] [Related]
72. LNX1 contributes to tumor growth by down-regulating p53 stability.
Park R; Kim H; Jang M; Jo D; Park YI; Namkoong S; Lee JI; Jang IS; Park J
FASEB J; 2019 Dec; 33(12):13216-13227. PubMed ID: 31533005
[TBL] [Abstract][Full Text] [Related]
73. Paracrine Placental Growth Factor Signaling in Response to Ionizing Radiation Is p53-Dependent and Contributes to Radioresistance.
Kazimova T; Tschanz F; Sharma A; Telarovic I; Wachtel M; Pedot G; Schäfer B; Pruschy M
Mol Cancer Res; 2021 Jun; 19(6):1051-1062. PubMed ID: 33619227
[TBL] [Abstract][Full Text] [Related]
74. The tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosis.
Cheng G; Kong D; Hou X; Liang B; He M; Liang N; Ma S; Liu X
Cancer Biother Radiopharm; 2013 Mar; 28(2):153-9. PubMed ID: 23268708
[TBL] [Abstract][Full Text] [Related]
75. Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells.
Chiu SJ; Hsaio CH; Tseng HH; Su YH; Shih WL; Lee JW; Chuah JQ
Biochem Biophys Res Commun; 2010 Apr; 394(3):774-9. PubMed ID: 20227390
[TBL] [Abstract][Full Text] [Related]
76. Inhibition of MDM2 by RG7388 confers hypersensitivity to X-radiation in xenograft models of childhood sarcoma.
Phelps D; Bondra K; Seum S; Chronowski C; Leasure J; Kurmasheva RT; Middleton S; Wang D; Mo X; Houghton PJ
Pediatr Blood Cancer; 2015 Aug; 62(8):1345-52. PubMed ID: 25832557
[TBL] [Abstract][Full Text] [Related]
77. Chemosensitization and radiosensitization of human cancer by antisense anti-MDM2 oligonucleotides: in vitro and in vivo activities and mechanisms.
Wang H; Oliver P; Zhang Z; Agrawal S; Zhang R
Ann N Y Acad Sci; 2003 Dec; 1002():217-35. PubMed ID: 14751837
[TBL] [Abstract][Full Text] [Related]
78. The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53.
Li WF; Herkilini A; Tang Y; Huang P; Song GB; Miyagishi M; Kasim V; Wu SR
Acta Pharmacol Sin; 2021 Nov; 42(11):1888-1899. PubMed ID: 33526870
[TBL] [Abstract][Full Text] [Related]
79. Radiosensitization of Adenoid Cystic Carcinoma with MDM2 Inhibition.
Prabakaran PJ; Javaid AM; Swick AD; Werner LR; Nickel KP; Sampene E; Hu R; Ong IM; Bruce JY; Hartig GK; Wieland AM; Canon J; Harari PM; Kimple RJ
Clin Cancer Res; 2017 Oct; 23(20):6044-6053. PubMed ID: 28659312
[No Abstract] [Full Text] [Related]
80. Caffeine enhances radiosensitization to orthotopic transplant LM3 hepatocellular carcinoma in vivo.
Wang TJ; Liu ZS; Zeng ZC; Du SS; Qiang M; Zhang SM; Zhang ZY; Tang ZY; Wu WZ; Zeng HY
Cancer Sci; 2010 Jun; 101(6):1440-6. PubMed ID: 20384627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
